Viral Prototypes for Pandemic Preparedness: The Road Ahead
The Journal of Infectious Diseases · 18.10.2023 · 228 (Supplement_6) · S460-S464
DOI: 10.1093/infdis/jiad267 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 18.10.2023. Verfasst von Kaitlyn M Morabito und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Mar…. Hauptthemen laut MEDLINE: COVID-19, Vaccines, Viral Vaccines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic demonstrated how rapidly vaccines and monoclonal antibodies (mAbs) could be deployed when the field is prepared to respond to a novel virus, serving as proof of concept that the prototype pathogen approach is feasible. This success was built upon decades of foundational research, including the characterization of protective antigens and coronavirus immunity leading to the development and validation of a generalizable vaccine approach for multiple coronaviruses. For other virus families of pandemic concern, the field is less prepared. The articles in this special issue have highlighted research gaps that need to be addressed to accelerate the development of effective vaccines and mAbs, to identify generalizable vaccine and mAb strategies, and to increase preparedness against other pandemic threats. Successful implementation of the prototype pathogen approach will require a systematic, multidisciplinary, coordinated approach with expertise and crosstalk among researchers of different virus families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Kaitlyn M Morabito
Förderung
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Morabito, K. M., Cassetti, M. C., DeRocco, A. J., Deschamps, A. M., & Pierson, T. C. (2023). Viral Prototypes for Pandemic Preparedness: The Road Ahead. The Journal of Infectious Diseases, 228(Supplement_6), S460-S464. https://doi.org/10.1093/infdis/jiad267
Vancouver
Morabito KM, Cassetti MC, DeRocco AJ, Deschamps AM, Pierson TC. Viral Prototypes for Pandemic Preparedness: The Road Ahead. The Journal of Infectious Diseases. 2023;228(Supplement_6):S460-S464. doi:10.1093/infdis/jiad267
BibTeX
@article{Morabito2023,
author = {Morabito, Kaitlyn M and Cassetti, M Cristina and DeRocco, Amanda J and Deschamps, Anne M and Pierson, Theodore C},
title = {Viral Prototypes for Pandemic Preparedness: The Road Ahead},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {228},
number = {Supplement_6},
pages = {S460--S464},
doi = {10.1093/infdis/jiad267}
}
EUVIMED